SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000914475-22-000028
Filing Date
2022-05-23
Accepted
2022-05-23 16:17:58
Documents
13
Period of Report
2022-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20220518.htm   iXBRL 8-K 59463
5 nbix-20220518_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-22-000028.txt   246370

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20220518.xsd EX-101.SCH 1908
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20220518_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20220518_pre.xml EX-101.PRE 12512
7 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20220518_htm.xml XML 10833
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 22951820
SIC: 2836 Biological Products, (No Diagnostic Substances)